Johnson & Johnson proposes $5.5 billion settlement to end marathon legal fight

Johnson & Johnson proposes a $5.5 billion settlement to resolve remaining lawsuits claiming its talc products caused ovarian cancer, conditional on 95% claimant participation. The settlement follows a rejected $9 billion proposal by subsidiary Red River Talc and aims to end a decade-long legal battle, with shares rising over 2% pre-market.